Myocardial infarction 1

Common Name(s)

Myocardial infarction 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Myocardial infarction 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Myocardial infarction 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Myocardial infarction 1" returned 209 free, full-text research articles on human participants. First 3 results:

Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium.
 

Author(s): Triston B Smith, Brian A Staub, Gayathri M Natarajan, David M Lasorda, Indu G Poornima

Journal: Tex Heart Inst J. 2014 Feb;41(1):70-2.

 

We describe the case of a previously healthy 22-year-old man who presented with anginal chest pain and was diagnosed with a non-ST-elevation myocardial infarction. For 3 weeks, he had been ingesting the dietary supplements Jack3d® (principal ingredient, 1,3-dimethylamylamine) and ...

Last Updated: 11 Feb 2014

Go To URL
Association between angiotensin II type 1 receptor polymorphism and sudden cardiac death in myocardial infarction.
 

Author(s): Peter Kruzliak, Gabriela Kovacova, Olga Pechanova, Stefan Balogh

Journal: Dis. Markers. 2013 ;35(5):287-93.

 

The renin-angiotensin system is involved in the pathogenesis of coronary artery disease and myocardial infarction (MI). Angiotensin II (Ang II) has many adverse effects such as vasoconstriction and vascular remodeling, and these actions are mediated by the angiotensin II type 1 receptor (AT1R).

Last Updated: 29 Oct 2013

Go To URL
Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence.
 

Author(s): Wei Liu, Xinmin Zhou, Fenglei Yu, Jianguo Hu, Wen Hu

Journal:

 

Activation of the renin-angiotensin system (RAS) plays a critical role in the pathophysiology of myocardial infarction (MI) and the development of heart failure. Both angiotensin-converting enzyme 2 (ACE2) and insulin/insulin receptor substrate-1 (IRS-1) show cardioprotective effects ...

Last Updated: 16 Jan 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Myocardial infarction 1" returned 9 free, full-text review articles on human participants. First 3 results:

Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.
 

Author(s): Jung Rae Cho, Fabiana Rollini, Francesco Franchi, Elisabetta Ferrante, Dominick J Angiolillo

Journal:

 

Platelet activation with subsequent aggregation is a complex process leading to thrombus formation, which remains a key component for atherothrombotic manifestations, in particular myocardial infarction. Therefore, antiplatelet therapies are pivotal for the treatment of these patients. ...

Last Updated: 14 Apr 2014

Go To URL
Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction.
 

Author(s): Christian Waeber, Thomas Walther

Journal: Circ. J.. 2014 ;78(4):795-802.

 

This review focuses on the role of sphingosine-1-phosphate (S1P) signaling in the heart, with particular emphasis on how it could be modulated therapeutically in the context of myocardial infarction (MI). After a brief general description of sphingolipid metabolism and signaling, ...

Last Updated: 27 Mar 2014

Go To URL
Natriuretic peptides as an adjunctive treatment for acute myocardial infarction: insights from the meta-analysis of 1,389 patients from 20 trials.
 

Author(s): Ting Lyu, Yichao Zhao, Tuo Zhang, Wen Zhou, Fan Yang, Heng Ge, Song Ding, Jun Pu, Ben He

Journal: Int Heart J. 2014 ;55(1):8-16.

 

Animal studies have reported a cardioprotective effect for atrial natriuretic peptide (ANP) or brain natriuretic peptide (BNP) administration in the setting of acute myocardial infarction (AMI). However, previous trials performed on AMI patients have reported differences in the cardiac ...

Last Updated: 13 Feb 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

GLP-1 Loading During Elective Percutaneous Coronary Intervention
 

Status: Not yet recruiting

Condition Summary: Angina Pectoris; Myocardial Infarction; Reperfusion Injury; Coronary Heart Disease

 

Last Updated: 29 Apr 2014

Go to URL
IL-1 Blockade in Acute Myocardial Infarction (VCU-ART3)
 

Status: Recruiting

Condition Summary: Acute Myocardial Infarction

 

Last Updated: 19 Aug 2014

Go to URL
Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack
 

Status: Recruiting

Condition Summary: Heart Failure; Myocardial Infarction

 

Last Updated: 6 Mar 2013

Go to URL